No Data
Medtronic Plc (NYSE:MDT) Is a Favorite Amongst Institutional Investors Who Own 87%
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
TD Cowen analyst Josh Jennings maintains $Medtronic(MDT.US)$ with a buy rating, and maintains the target price at $95.According to TipRanks data, the analyst has a success rate of 53.2% and a total
Medtronic's Stable Outlook and Growth Prospects Reinforce Buy Rating
Mizuho Securities Cuts Price Target on Medtronic to $95 From $98
Medtronic (MDT) has an average rating of outperform and price targets ranging from $76 to $112, according to analysts by Capital IQ.Price: 77.39, Change: -0.68, Percent Change: -0.87
Express News | Citigroup Maintains Neutral on Medtronic, Lowers Price Target to $85
Medtronic Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 10.3% Citigroup $90 → $85 Maintains Neutral 06/05/2024 19.38% RBC Capital $92 → $92
101550592 :![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d.png)
102188459 : Tq
Paul bin Anthony : very good test for myself first and second give your best price for your wonderful family together with this tq God bless All rights reserved to Babylon Amen![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f.png)
![people_hugging 🫂](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1fac2.png)